Company Overview - Mobile-health Network Solutions (MNDR) is a pioneering MedTech company focused on enhancing human connection through technology [1] - The company is ranked 41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies and is the first telehealth provider from the Asia-Pacific region to be listed in the US [4] - MNDR offers a range of telehealth solutions including teleconsultation services, prescription fulfillment, and personalized services such as weight management programs and gender-specific care [4] Upcoming Events - MNDR will present at the Centurion One Capital 8th Annual Growth Conference from March 3rd to March 6th, 2025, at the Four Seasons Hotel in Toronto [1][3] - Co-founders and co-CEOs, Dr. Tung Yeng Siaw and Dr. Rachel Teoh, are scheduled to present on March 6th, 2025, focusing on the company's latest AI technology innovations [2] - The presentation will include the newly deployed AI Agent platform aimed at improving healthcare providers' workflow efficiency [2] Industry Context - The telehealth solutions industry is experiencing growth, with MNDR positioned to capitalize on this trend through its innovative technology and services [4] - Centurion One Capital, the investment banking firm hosting the conference, is dedicated to supporting the growth of companies in North America, indicating a favorable environment for investment in the sector [5][6]

Core Insights - The launch of ManaSocial positions Mobile-health Network Solutions (MNDR) as a leader in the digital health market, enhancing user engagement and creating new revenue opportunities [2][3][11] Group 1: Strategic Highlights - ManaSocial is a key component of MNDR's growth strategy, leveraging the potential of the digital health sector [3] - The platform introduces multiple monetization avenues, including subscription and advertising revenue [4][14] - It offers monetizable B2B tools for clinics and healthcare organizations to enhance their digital presence [5] Group 2: Market Potential - The global digital health market is expected to exceed $500 billion by 2030, with a CAGR of over 27%, providing a significant opportunity for MNDR [6] - ManaSocial aims to capture a substantial share of this market by addressing both consumer and enterprise needs [6][17] Group 3: User Engagement - ManaSocial features 'Medutainment' tools that combine medical education with entertainment, driving user engagement and retention [7] - The platform facilitates community-driven healthcare discussions, enhancing user interaction [10] Group 4: Competitive Advantage - ManaSocial differentiates itself from traditional telemedicine platforms through verified expertise and a holistic approach to wellness [9][16] - The platform's community-driven model fosters trust and collaboration among users [9] Group 5: Global Expansion - ManaSocial connects users with localized healthcare content, enabling MNDR to penetrate underserved markets and scale operations internationally [8][17] Group 6: Long-Term Growth - The launch of ManaSocial aligns with MNDR's commitment to innovation in the MedTech space, positioning the company to meet the growing demand for digital healthcare solutions [11][18] - The platform is expected to significantly contribute to MNDR's top-line growth by enhancing user acquisition and retention [19]

Business Expansion and Market Risks - The company plans to expand its business into new jurisdictions, which may introduce risks such as regulatory compliance challenges and operational management difficulties[11]. - The company may encounter difficulties in managing the complexity of its operations as it expands, potentially affecting its financial condition and operational results[10]. - The anticipated benefits from growth initiatives may not materialize as expected, leading to potential adverse effects on the company's financial performance[12]. - The company faces risks from political, economic, and regulatory environments in Singapore and Malaysia, which could adversely affect its operations[40]. - The company aims to expand its service offerings along the healthcare value chain, including targeted campaigns and workshops for medical professionals[85]. - The anticipated expansion includes reaching new markets in the APAC region, such as Malaysia, the Philippines, and Vietnam, through strategic partnerships and acquisitions[85]. Financial Performance and Revenue - Total revenue increased by approximately 77.2%, from US$7.9 million in the year ended June 30, 2023, to US$14.0 million in the year ended June 30, 2024[82]. - Revenue increased by 77.4% to $13.9 million for the financial year ended June 30, 2024, compared to $7.9 million for the previous year[124]. - Telemedicine revenue from the private sector rose to $12.6 million, an increase of 88.4% from $6.7 million in the prior year, while public sector revenue dropped significantly[126]. - The number of private telemedicine transactions increased by 70.4% to 1,547 for the financial year ended June 30, 2024, compared to 908 in the previous year[128]. - The company incurred a net loss of $15.6 million for the financial year ended June 30, 2024, compared to a net loss of $3.2 million in 2023[138]. - Cash and cash equivalents as of June 30, 2024, were approximately $6.7 million, providing liquidity for operations[138]. Technology and Innovation - The company is investing significantly in upgrading its technology infrastructure to enhance performance and functionality, which may require substantial resources and time[17]. - The integration of Generative AI into the platform presents potential risks, including data breaches and regulatory compliance challenges, which could impact patient care and business operations[18]. - The company plans to enhance user engagement through data-driven and predictive healthcare services, incorporating smart predictive AI into its mobile application and website[84]. - The company aims to develop a next-generation healthcare operating system to connect patients with healthcare services more intuitively and efficiently[84]. - The company plans to implement blockchain technology for decentralized storage of user data, enhancing user control over personal information[84]. Regulatory Compliance and Legal Risks - Compliance with privacy laws regarding patient health information is crucial, as violations could result in significant penalties and harm to the company's reputation[18]. - The company must comply with various regulatory requirements in Singapore, and failure to maintain necessary approvals could lead to operational disruptions and financial penalties[21]. - The company faces substantial litigation and regulatory risks, including potential claims and lawsuits that could adversely affect its financial condition and reputation[10]. - The Healthcare Services Act 2020 (HCSA) replaced the Private Hospitals and Medical Clinics Act, with full implementation completed by the end of 2023[113]. - Penalties for non-compliance under the HCSA include fines up to S$100,000 or imprisonment for up to two years for serious offenses[113]. User Engagement and Service Quality - The MaNaDr platform offers a 24/7 virtual care ecosystem, providing users with timely access to healthcare professionals[75]. - The company has implemented quality control standards for its MaNaDr platform, but there is no assurance that these measures will be sufficient to ensure service quality[19]. - The company has developed a three-tier quality control system for teleconsulting services, ensuring high standards of medical care[104]. - The MaNaDr platform operates Singapore's only in-app live group chat service, providing 24/7 support and enhancing user experience[78]. - The company has established a comprehensive risk management system to minimize medical risks, with no medical malpractice claims reported during the years ended June 30, 2024, and 2023[102]. Competition and Market Position - The company faces intense competition for skilled medical professionals and support staff, which may lead to increased compensation costs[36]. - The Singapore telehealth solutions market is expected to grow significantly, driven by increasing disposable income and healthcare awareness, positioning the company to benefit from this growth[77]. - The company operates in a competitive healthcare market, with a focus on family medicine and health IT services[142]. Corporate Governance and Management - The company is currently classified as an "emerging growth company" and may take advantage of reduced reporting requirements until it meets certain thresholds, such as total annual gross revenue of at least $1.235 billion[66]. - The company has established an audit committee, a compensation committee, and a nominations committee, all composed of independent directors[151]. - The board of directors consists of 5 members, with 1 female and 4 male directors, indicating a gender diversity ratio of 20% female[147]. - The company has a diverse executive team, including a Chief Financial Officer and a Chief Technology Officer, enhancing its operational capabilities[143]. Risk Management and Cybersecurity - The company processes a large amount of sensitive user data, which poses risks related to data security and compliance with privacy regulations[24]. - The company may incur significant costs related to cybersecurity breaches, which could harm its reputation and financial condition[10]. - The company has conducted ongoing assessments of cybersecurity risks to its information systems[200]. Intellectual Property and Innovation - The company relies on intellectual property protections, but faces challenges in enforcing these rights, which could impact its competitive position[27]. - As of June 30, 2024, the company had registered 22 trademarks and 2 patents in Singapore, reflecting its commitment to protecting intellectual property[108]. Employee and Executive Compensation - For the year ended June 30, 2023, the company incurred compensation of approximately S$1,103,000 (US$818,000) to executive officers and S$5,200 (US$38,000) to non-executive directors[149]. - The Employee Incentive Plan adopted in March 2023 allows for the issuance of shares up to 10% of the total issued Class A Ordinary Shares, with options granted at US$1.0 per share[162]. Financial Reporting and Audit - The financial statements are prepared in accordance with US GAAP, with the reporting currency being the US dollar[211]. - The company has determined that there were no material weaknesses in internal control over financial reporting as of June 30, 2024[191]. - The audit committee oversees the accounting and financial reporting processes and the audits of the financial statements of the company[151].